Study of the Absorption, Metabolism, and Excretion of [14C]-Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) Following a Single Oral Dose in Healthy Male Subjects
Clinical trial NCT04625855 · COMPLETED
Trial details
- NCT number
- NCT04625855
- Sponsor
- Spero Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-30
- Primary completion
- 2020-10-16
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.